Live Crown Castle Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Exousia Bio, Inc.

LMMY

Latest SEC Filings from Exousia Bio, Inc.

  1. 1
    1

    Exousia Bio Reports No Revenue and $50,897 Net Loss for Nine Months Ending February 28, 2026

    via official filing (AI summary) 4 months ago 0 comments
  2. 2
    1

    Exousia Bio Reports No Revenue and Increased Losses Following Acquisition of Exousia AI

    via official filing (AI summary) 7 months ago 0 comments
  3. 3
    1

    LAMY Reports No Revenue and Increased Losses in Latest Financial Results

    via official filing (AI summary) 11 months ago 0 comments
  4. 4
    1

    LAMY Reports Revenue Decline to $3,750 but Achieves Net Income Turnaround

    via official filing (AI summary) about 1 year ago 0 comments
  5. 5
    1

    LAMY Reports 51% Revenue Decline, Achieves Net Income Turnaround for Nine Months Ending February 2025

    via official filing (AI summary) over 1 year ago 0 comments
  6. 6
    1

    L A M Y Reports Net Income Recovery to $80,129 Despite No Revenue

    via official filing (AI summary) almost 2 years ago 0 comments
  7. 7
    1

    Lamy Reports Revenue Growth, Net Loss Improvement in Q3 2024

    via official filing (AI summary) about 2 years ago 0 comments